These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 6144670)
21. A double blind trial of nitrazepam and flurazepam as sedatives. James NM N Z Med J; 1975 Mar; 81(535):246-8. PubMed ID: 236528 [TBL] [Abstract][Full Text] [Related]
22. The side effect profile of buspirone in comparison to active controls and placebo. Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065 [TBL] [Abstract][Full Text] [Related]
23. Preference studies of triazolam with standard hypnotics in out-patients with insomnia. Fabre LF; McLendon DM; Harris RT J Int Med Res; 1976; 4(4):247-54. PubMed ID: 16801 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of lormetazepam and flurazepam in the treatment of insomnia. Melo de Paula AJ Clin Ther; 1984; 6(4):500-8. PubMed ID: 6380724 [TBL] [Abstract][Full Text] [Related]
26. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. Rothschild AJ J Clin Psychiatry; 1992 Dec; 53 Suppl():69-79. PubMed ID: 1487483 [TBL] [Abstract][Full Text] [Related]
27. A review of the safety profiles of benzodiazepine hypnotics. Roth T; Roehrs TA J Clin Psychiatry; 1991 Sep; 52 Suppl():38-41. PubMed ID: 1680124 [TBL] [Abstract][Full Text] [Related]
28. On the dose equivalence of flurazepam and triazolam. Gorenstein C; Gentil V; Ragazzo PC; Manzano G; Arruda PV; Peres CA Braz J Med Biol Res; 1986; 19(2):173-82. PubMed ID: 3828570 [TBL] [Abstract][Full Text] [Related]
33. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety. Small GW; Bystritsky A J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045 [TBL] [Abstract][Full Text] [Related]
34. [Experimental double-blind study of triazolam versus placebo]. Sbarbaro V; Gambina G; Bovi P; Trabucco G; Signori L; Varricchio MC Clin Ter; 1981 May; 97(3):253-69. PubMed ID: 6116556 [No Abstract] [Full Text] [Related]
35. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Johnson MW; Suess PE; Griffiths RR Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817 [TBL] [Abstract][Full Text] [Related]
36. Quazepam versus triazolam in patients with sleep disorders: a double-blind study. Mauri MC; Gianetti S; Pugnetti L; Altamura AC Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174 [TBL] [Abstract][Full Text] [Related]
37. [Triazolam and flunitrazepam in a double-blind cross-over trial]. Pöldinger W Ther Umsch; 1983 Sep; 40(9):810-6. PubMed ID: 6138875 [No Abstract] [Full Text] [Related]
38. Evaluation of single-dose hypnotic treatment before elective operation. Keighley MR; Gannon M; Warlow J; Jenkins CR; Gammon RJ Br Med J; 1980 Sep; 281(6244):829-31. PubMed ID: 6107159 [TBL] [Abstract][Full Text] [Related]
40. A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs. Vogel GW; Barker K; Gibbons P; Thurmond A Psychopharmacology (Berl); 1976 May; 47(1):81-6. PubMed ID: 8813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]